A prospective study to investigate clinical factors predicting hepatocarcinogenesis after the eradication of hepatitis C virus.
Not Applicable
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000028448
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients without any evaluation of the efficacy of anti-HCV therapy. 2. Patients whose clinical course after anti-HCV therapy cannot be tracked.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical factors associated with hepatocarcinogenesis after HCV eradication.
- Secondary Outcome Measures
Name Time Method Cancer-free survival time after HCV eradication